{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:12:43Z","timestamp":1781770363668,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":969,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.fertnstert.2019.06.009","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T07:46:42Z","timestamp":1564386402000},"page":"677-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-7043","authenticated-orcid":false,"given":"Sule","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5008-3292","authenticated-orcid":false,"given":"Engin","family":"Turkgeldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berk","family":"Angun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Eraslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Urman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-3747","authenticated-orcid":false,"given":"Baris","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2019.06.009_bib1","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/humupd\/dml020","article-title":"Ovarian feedback, mechanism of action and possible clinical implications","volume":"12","author":"Messinis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1365-2265.1997.3461141.x","article-title":"Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy","volume":"47","author":"Alexandris","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in\u00a0vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/jcem-58-2-378","article-title":"Progesterone modulation of pulsatile luteinizing hormone secretion in normal women","volume":"58","author":"Soules","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in\u00a0vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11596-018-1908-z","article-title":"Effect of progestin-primed ovarian stimulation protocol on outcomes of aged infertile women who failed to get pregnant in the first IVF\/ICSI cycle: a self-controlled study","volume":"38","author":"Chen","year":"2018","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/humrep\/dez034","article-title":"Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial","volume":"34","author":"Begueria","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in\u00a0vitro fertilisation: a randomised controlled trial","volume":"124","author":"Dong","year":"2017","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib10","doi-asserted-by":"crossref","first-page":"e4193","DOI":"10.1097\/MD.0000000000004193","article-title":"The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF\/ICSI treatments","volume":"95","author":"Zhu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.fertnstert.2016.10.030","volume":"107","author":"Zhu","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2017.06.017","article-title":"Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in\u00a0vitro fertilization\/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation","volume":"108","author":"Zhu","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib14","doi-asserted-by":"crossref","first-page":"e2939","DOI":"10.1097\/MD.0000000000002939","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.fertnstert.2004.06.021","article-title":"Guidelines for oocyte donation","volume":"82","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1210\/endo-109-4-1293","article-title":"On the site of action of progesterone in the blockade of the estradiol-induced gonadotropin discharge in the rhesus monkey","volume":"109","author":"Wildt","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2826.2005.01287.x","article-title":"Progesterone can block the preovulatory gonadotropin-releasing hormone\/luteinising hormone surge in the ewe by a direct inhibitory action on oestradiol-responsive cells within the hypothalamus","volume":"17","author":"Richter","year":"2005","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000054656","article-title":"Progesterone treatment that either blocks or augments the estradiol-induced gonadotropin-releasing hormone surge is associated with different patterns of hypothalamic neural activation","volume":"73","author":"Richter","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/humupd\/dmr039","article-title":"Ovarian antral folliculogenesis during the human menstrual cycle: a review","volume":"18","author":"Baerwald","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0015-0282(03)00544-2","article-title":"A new model for ovarian follicular development during the human menstrual cycle","volume":"80","author":"Baerwald","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib21","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.fertnstert.2008.08.011","article-title":"Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase","volume":"92","author":"von Wolff","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib22","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.fertnstert.2013.07.1992","article-title":"Effective method for emergency fertility preservation: random-start controlled ovarian stimulation","volume":"100","author":"Cakmak","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/humrep\/dev339","article-title":"A fresh look at the freeze-all protocol: a SWOT analysis","volume":"31","author":"Blockeel","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","article-title":"Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol)","volume":"29","author":"Kuang","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib25","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/humrep\/dey217","article-title":"Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle","volume":"33","author":"Cimadomo","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib26","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.fertnstert.2016.03.002","article-title":"Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation","volume":"105","author":"Ubaldi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.06.009_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-018-0335-0","article-title":"An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders","volume":"16","author":"Huang","year":"2018","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028219305072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028219305072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:24:32Z","timestamp":1758011072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028219305072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0015028219305072"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.06.009","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92019 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}